Target intelligence / Profile preview

Androctonus amoreuxi venom toxins (Amm toxins)

Target
Amm toxins
Molecular classification
Scorpion venom peptides, Neurotoxins, Ion channel modulators
01

Overview

Androctonus amoreuxi venom toxins are a diverse group of small, disulfide-rich peptides produced by the African fat-tailed scorpion (UniProt: P01481). These toxins primarily target voltage-gated ion channels, specifically sodium (Nav) and potassium (Kv) channels, which are critical for electrical signaling in excitable tissues (PubMed: 15541660). The most potent components are alpha-neurotoxins, such as Amm II, which bind to site 3 of sodium channels to inhibit inactivation, leading to persistent depolarization and massive neurotransmitter release (PubMed: 11036108). Clinically, these toxins cause severe envenomation characterized by autonomic hyperactivity, cardiac arrhythmias, and respiratory failure (Toxicon, 2004). In a therapeutic context, these toxins are the primary targets for polyvalent or monovalent antivenoms, which utilize purified antibodies to neutralize the peptides before they can bind to their physiological targets (PubMed: 12165314). Beyond toxicology, these toxins serve as high-affinity probes in pharmacological research to study the structure and function of ion channels.

Other names
Amm toxinsAfrican fat-tailed scorpion toxinsAndroctonus amoreuxi neurotoxinsSahara scorpion toxins
02

Mechanism of action

Neutralization of toxin activity through antibody-mediated sequestration, preventing the toxins from binding to voltage-gated ion channels (PubMed: 12165314).

03

Biological functions

Ion channel modulationNeurotoxicityDisruption of action potential propagationInduction of neurotransmitter release
04

Disease associations

Scorpion envenomationAutonomic nervous system dysfunctionCardiovascular distressRespiratory failure
05

Safety considerations

High lethalityRapid systemic distributionPotential for anaphylactic shock from antivenom (PubMed: 12165314)Severe autonomic storm
06

Interacting drugs

Scorpion antivenom

1 more in the full profile.

07

Biomarkers

Serum venom antigen levels (PubMed: 11036108)Creatine kinaseBlood glucose levels

Beyond the preview

Go deeper on Androctonus amoreuxi venom toxins (Amm toxins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Androctonus amoreuxi venom toxins (Amm toxins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call